Kite vs Mira — how do they compare? Kite trades at Rp1,704 (market cap Rp3,02T, Rp249,92M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Kite is far larger — about 13337.5× Mira's market cap, and Kite's circulating supply is 1,8B / 10B KITE (18%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Kite for 7 Days and Mira for 22 Days on average.
| KITE | MIRA | |
|---|---|---|
Market Cap | Rp3,02T | Rp226,43M |
Volume (24h) | Rp249,92M | Rp101,47M |
Circulating Supply | 1,8B / 10B KITE (18%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 7 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
KITE is currently trading at Rp1,779 with a market cap of Rp3.22 trillion, showing bearish technical signals as it hovers near support at Rp1,780. The token has only 18% of its maximum 10 million supply in circulation, with neutral oscillators but bearish moving averages suggesting short-term pressure. No recent protocol updates or ecosystem developments were identified during analysis.
Overall outlook remains cautious with key opportunities in the low circulating supply potential, while major risks include technical bearish momentum, limited liquidity, and the absence of recent ecosystem developments. Investors should monitor for breaking support levels and watch for any upcoming protocol announcements.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Kite is building the first AI-focused payment blockchain, enabling autonomous AI agents to transact with verifiable identity, programmable governance, and native stablecoin access. It provides the core infrastructure for AI systems to operate safely on-chain.
Read more on KITE →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →